SOL Global Divests Securities in Captor Capital
Toronto, Ontario–(Newsfile Corp. – January 4, 2023) – SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) (“SOL Global” or the “Company”) announces that the Company transferred and divested an aggregate of 4,182,316 common shares (“Captor more...
New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy
Owen Hughes appointed Executive Chairman of the Board of Directors and Brad Sitko joins as Chief Investment Officer EMERYVILLE, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today more...
Aravive Announces Complete Enrollment in the Global Registrational Phase 3 AXLerate-OC Trial for Platinum-Resistant Ovarian Cancer
Topline data expected mid-2023 Potential Biologics License Application (BLA) submission end of 2023 HOUSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV, the “Company”), a late clinical-stage oncology company developing targeted therapeutics to more...
BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer
BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer PR Newswire Experienced Drug Developer Brings Over 15 Years of Clinical Development Industry Knowledge across Multiple Therapeutic Areas and Modalities TEL AVIV, Israel , Jan. 4, more...
EyePoint Pharmaceuticals Promotes Jay S. Duker, M.D. to President and Chief Operating Officer
Dr. Duker has served as EyePoint’s Chief Operating Officer since November 2021 WATERTOWN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to more...
Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatments for Diabetes
Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatments for Diabetes Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced more...
NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
SHELTON, CT / ACCESSWIRE / January 4, 2023 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), announces that the Company’s President, Dr. Anil Diwan, will be presenting a talk in person at the Biotech Showcase™ 2023 more...
ReneSola Power Announces a Share Repurchase Transaction
ReneSola Power Announces a Share Repurchase Transaction PR Newswire STAMFORD, Conn. , Jan. 4, 2023 /PRNewswire/ — ReneSola Ltd (“ReneSola Power” or the “Company”) ( www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project more...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vintage Wine, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Vintage Wine more...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigatio – BLRX
NEW YORK, NY / ACCESSWIRE / January 3, 2023 / WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential civil securities claims on behalf of shareholders of BioLineRx Ltd. more...